Rapid diagnostic HCV antibody assays
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Rapid diagnostic HCV antibody assays
Filetype[PDF-57.88 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 321.94 KB]
    Personal Author:
    Jewett, A.; Smith, B.D.; Garfein, R.S.; Cuevas-Mota, J.; Teshale, E.H.; Weinbaum, C.M.;
    Published Date:
    May 03 2012
    Source:
    J Clin Virol. 54(3):213-217.
    Description:
    BackgroundApproximately 4.1 million Americans are estimated to have been infected with hepatitis C virus (HCV), 45–85% of whom are unaware of their infection. Persons who inject drugs (PWID) account for 55.8% of all persons with HCV antibody (anti-...
    File Type:
    Filetype[PDF - 321.94 KB]
  2. Filetype[PDF - 239.12 KB]
    Personal Author:
    Smith, Bryce D.; Yartel, Anthony K.;
    Published Date:
    Sep 2014
    Source:
    Am J Prev Med. 47(3):233-241.
    Description:
    BackgroundHepatitis C virus (HCV) infection is unidentified in an estimated 40%–85% of infected adults. Surveillance and modeling data have found significant increases in HCV-associated morbidity and mortality.PurposeTo compare two HCV antibody (an...
    File Type:
    Filetype[PDF - 239.12 KB]
  3. Filetype[PDF - 236.83 KB]
    Personal Author:
    Getchell, Jane P.; Wroblewski, Kelly E.; DeMaria, Alfred; Bean, Christine L.; Parker, Monica M.; Pandori, Mark; Dufour, D. Robert; Busch, Michael P.; Brecher, Mark E.; Meyer, William A.; Pesano, Rick L.; Teo, Chong-Gee; Beckett, Geoffrey A.; Araujo, Aufra C.; Branson, Bernard M.; Drobeniuc, Jan; Hatia, Rikita; Holmberg, Scott D.; Kamili, Saleem; Ward, John W.;
    Published Date:
    May 10 2013
    Source:
    MMWR Morb Mortal Wkly Rep. 2013; 62(18):362-365.
    Description:
    In the United States, an estimated 4.1 million persons have been infected with hepatitis C virus (HCV), of whom an estimated 3.2 (95% confidence interval [CI] = 2.7-3.9) million are living with the infection. New infections continue to be reported pa...
    File Type:
    Filetype[PDF - 236.83 KB]
  4. Filetype[PDF - 129.05 KB]
    Corporate Authors:
    Association of Public Health Laboratories (U.S.). Centers for Disease Control and Prevention (U.S.).
    Published Date:
    May 10, 2013
    Series:
    MMWR. Morbidity and mortality weekly report ; 62(18):362-5
    Description:
    In the United States, an estimated 4.1 million persons have been infected with hepatitis C virus (HCV), of whom an estimated 3.2 (95% confidence interval [CI] = 2.7–3.9) million are living with the infection. New infections continue to be reported ...
    Status:
    current
    File Type:
    Filetype[PDF - 129.05 KB]
  5. Filetype[PDF - 410.23 KB]
    Personal Author:
    Campo, David S.; Dimitrova, Zoya; Yokosawa, Jonny; Hoang, Duc; Perez, Nestor O.; Ramachandran, Sumathi; Khudyakov, Yury;
    Published Date:
    Feb 15 2012
    Source:
    Sci Rep. 2012; 2.
    Description:
    Vaccine development against hepatitis C virus (HCV) is hindered by poor understanding of factors defining cross-immunoreactivity among heterogeneous epitopes. Using synthetic peptides and mouse immunization as a model, we conducted a quantitative ana...
    File Type:
    Filetype[PDF - 410.23 KB]